Via: Drugs (e-mail list )
Recommendations from the 8th Meeting of WHO Advisory Committee on Safety of Medicinal Products are available.
The WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003 to provide advice to WHO, including its Collaborating Centre for International Drug Monitoring (the UMC), and through it, to the Member States of WHO, on safety issues relating to medicinal products. It guides WHO on general and specific issues related to Pharmacovigilance (PV). The Committee is composed of 12 members drawn from the WHO Expert Advisory Panels for Drug Evaluation and for Drug Policies and Management and, where appropriate, in consultation with other relevant WHO clusters and expert advisory panels. ACSoMP meets once a year to discuss ongoing and new PV topics, with particular focus on issues related to public health programmes.
The eighth ACSoMP meeting was held in WHO Headquarters, Geneva between 31 March and 1 April 2011. The summary of the meeting discussions and recommendations are available on the WHO website at the following link:
With best wishes,